Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.

Manne SL, Chung DC, Weinberg DS, Vig HS, Catts Z, Cabral MK, Shannon K, Meropol NJ.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2110-7.

2.

Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.

Landsbergen KM, Prins JB, Brunner HG, Hoogerbrugge N.

Genet Couns. 2009;20(4):317-25.

PMID:
20162866
3.

Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.

Van Lier MG, De Wilt JH, Wagemakers JJ, Dinjens WN, Damhuis RA, Wagner A, Kuipers EJ, Van Leerdam ME.

Scand J Gastroenterol. 2009;44(5):600-4. doi: 10.1080/00365520802706008.

PMID:
19153873
4.

Intention to learn results of genetic testing for hereditary colon cancer.

Vernon SW, Gritz ER, Peterson SK, Perz CA, Marani S, Amos CI, Baile WF.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):353-60.

5.

Motivations and psychosocial impact of genetic testing for HNPCC.

Esplen MJ, Madlensky L, Butler K, McKinnon W, Bapat B, Wong J, Aronson M, Gallinger S.

Am J Med Genet. 2001 Sep 15;103(1):9-15.

PMID:
11562928
6.

Attitudes toward colon cancer gene testing: factors predicting test uptake.

Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, Brensinger JD, Johnson K, Bacon JA, Booker SV.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):345-51.

7.

Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist's initiative.

Landsbergen KM, Prins JB, Brunner HG, van Duijvendijk P, Nagengast FM, van Krieken JH, Ligtenberg M, Hoogerbrugge N.

Fam Cancer. 2012 Jun;11(2):259-67. doi: 10.1007/s10689-012-9510-1.

8.

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.

Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frébourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H.

Am J Gastroenterol. 2008 Nov;103(11):2825-35; quiz 2836. doi: 10.1111/j.1572-0241.2008.02084.x. Epub 2008 Aug 27.

PMID:
18759827
9.

Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.

Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu X.

Scand J Gastroenterol. 2011 Nov;46(11):1340-8. doi: 10.3109/00365521.2011.610003. Epub 2011 Aug 31.

PMID:
21879804
10.

Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.

Wakefield CE, Meiser B, Homewood J, Peate M, Kirk J, Warner B, Lobb E, Gaff C, Tucker K.

J Genet Couns. 2007 Jun;16(3):325-39. Epub 2007 Feb 23.

PMID:
17318456
11.

Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.

Valle L, Perea J, Carbonell P, Fernandez V, Dotor AM, Benitez J, Urioste M.

J Clin Oncol. 2007 Mar 1;25(7):781-6. Epub 2007 Jan 16.

PMID:
17228022
12.

[Genetics analysis of microsatellite instability in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families].

Smolarz B, Langner E, Romanowicz-Makowska H, Kozłowska E, Kulig A, Dziki A.

Pol Merkur Lekarski. 2006 Jul;21(121):20-3. Polish.

PMID:
17007286
13.

Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.

Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E.

Patient Educ Couns. 2004 Nov;55(2):265-74.

PMID:
15530764
14.

[More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].

de Bruin JH, Kievit W, Ligtenberg MJ, Nagengast FM, Adang EM, Ruers TJ, Kleibeuker JH, Sijmons RH, van Krieken JH, Hoogerbrugge N.

Ned Tijdschr Geneeskd. 2005 Aug 6;149(32):1792-8. Dutch.

PMID:
16121665
15.

Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling.

Keller M, Jost R, Kadmon M, Wüllenweber HP, Haunstetter CM, Willeke F, Jung C, Gebert J, Sutter C, Herfarth C, Büchler MW.

Dis Colon Rectum. 2004 Feb;47(2):153-62.

PMID:
15043284
16.

Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.

Strul H, Liberman E, Kariv R, Gartner M, Kazanov D, Keidar A, Carmeli Y, Degani Y, Halpern Z, Arber N.

J Med. 2003;34(1-6):139-48.

PMID:
17682319
17.

Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.

Wakefield CE, Meiser B, Homewood J, Ward R, O'Donnell S, Kirk J; Australian GENetic testing Decision Aid Collaborative Group.

Cancer. 2008 Sep 1;113(5):956-65. doi: 10.1002/cncr.23681.

18.

Attitudes toward genetic testing in patients with colorectal cancer.

Kinney AY, Choi YA, DeVellis B, Millikan R, Kobetz E, Sandler RS.

Cancer Pract. 2000 Jul-Aug;8(4):178-86.

PMID:
11898257
19.

Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.

Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ, Steinberg SM, Kirsch I.

Arch Intern Med. 2003 Mar 10;163(5):573-82.

PMID:
12622604
20.

Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model.

Manne S, Markowitz A, Winawer S, Guillem J, Meropol NJ, Haller D, Jandorf L, Rakowski W, Babb J, Duncan T.

Prev Med. 2003 Jan;36(1):71-84.

PMID:
12473427

Supplemental Content

Support Center